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Weighted-SAMGSR: combining significance
analysis of microarray-gene set reduction
algorithm with pathway topology-based
weights to select relevant genes
Suyan Tian1,2*, Howard H. Chang3 and Chi Wang4

Abstract
Background: It has been demonstrated that a pathway-based feature selection method that incorporates
biological information within pathways during the process of feature selection usually outperforms a gene-based
feature selection algorithm in terms of predictive accuracy and stability. Significance analysis of microarray-gene set
reduction algorithm (SAMGSR), an extension to a gene set analysis method with further reduction of the selected
pathways to their respective core subsets, can be regarded as a pathway-based feature selection method.
Methods: In SAMGSR, whether a gene is selected is mainly determined by its expression difference between the
phenotypes, and partially by the number of pathways to which this gene belongs. It ignores the topology information
among pathways. In this study, we propose a weighted version of the SAMGSR algorithm by constructing weights
based on the connectivity among genes and then combing these weights with the test statistics.
Results: Using both simulated and real-world data, we evaluate the performance of the proposed SAMGSR extension
and demonstrate that the weighted version outperforms its original version.
Conclusions: To conclude, the additional gene connectivity information does faciliatate feature selection.
Reviewers: This article was reviewed by Drs. Limsoon Wong, Lev Klebanov, and, I. King Jordan.
Keywords: Pathway knowledge, Pathway-based feature selection, Significance analysis of microarray (SAM), Weighted
gene expression profiles, Non-small cell lung cancer (NSCLC), Multiple sclerosis (MS)

Background
Many studies have demonstrated that pathway-based
feature selection algorithms, which utilize biological
information contained in pathways to guide which
features/genes should be selected, are usually superior to
traditional gene-based feature selection algorithms in
terms of predictive accuracy, stability, and biological
interpretation [1–10]. Consequently, pathway-based
feature selection algorithms have become increasingly
popular and widespread.
* Correspondence: stian@rockefeller.edu
1
Division of Clinical Research, The First Hospital of Jilin University, 71Xinmin
Street, Changchun, Jilin, China 130021
2
School of Mathematics, Jilin University, 2699 Qianjin Street, Changchun, Jilin,
China 130012
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In contrast to a pathway analysis method, which
examines the association of a whole pathway with the
phenotype of interest, a pathway-based feature selection
algorithm focuses on the identification of relevant
individual features (e.g., genes) while considering known
pathway knowledge. Pathway-based feature selection
algorithms can be classified into three major categories –
penalty, stepwise forward, and weighting. Their definitions
and characteristics are presented in Table 1. In the penalty
category, an additional penalty term accounting for the
pathway structure/topology is added to the objective function for optimization. In essence, this penalty term provides some smoothness on nearby genes within a pathway,
relying on the assumption that neighboring genes inside a
pathway are more likely to function together or to be
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Table 1 Three categories of pathway-based feature selection algorithms. The filter and embedded methods are two typical types
for the gene-based feature selection algorithms. As defined by [32], filter methods access the relevance of features by calculating
some functional score while embedded methods search for the optimal subset simultaneously with the classifier construction
Category/description

Property

Pathway topology information Examples [Ref.]

Penalty: add an extra penalty term which
accounts for the pathway structure to the
objective function, then optimize the
resulting function to get the final gene subset

Embedded feature selection methods,
carry out feature selection and
coefficient estimation simultaneously,
moderate to heavy computing burden

Need the pathway topology
information for all genes, e.g.,
are they connected and the
distance between them

Net-Cox [Zhang
et al. 2013] netSVM
[Chen et al. 2011]

Usually ignore the pathway
topology information, the
decision hinges mainly on
the genes’ expression values

SAM-GSR
[Dinu et al, 2009]
SurvNet [Li et al. 2012]

Stepwise forward: order genes based on one
Usually filter methods, the beneath
specific statistic, and then add gene one by one concepts and theory are simple. However,
until there is no gain on the pre-defined score. they also inherits the filter methods’
drawbacks of inferior model parsimony
and thus high false positive rate.
Weighting: create some kind weights according
to the pathway knowledge and then combine
with other feature selection methods to identify
the relevant genes

With different weights, the chance of
Account for the pathway
those “driving” genes with subtle change topology information.
being selected increases. However, if the
estimated weights subject to big biases,
the resulting model might even be inferior
to those without weights.

involved in the same biological process than those are far
away. As a result, a ‘driving’ gene that has subtle changes
but alters its neighbors’ expression values dramatically is
more likely to be selected. One limitation of penalization
methods is that they are associated with higher theoretical
complexity and more computational efforts.
The stepwise forward methods first select one gene
(e.g., the most significantly differentially expressed) and
add genes gradually, and then evaluate the performance
of the resulting gene subset based on some statistic until
no further gain upon this statistic can be obtained. The
SAMGSR algorithm proposed by [11] falls within this
category, and it consists of two steps. Its first step is
essentially an extension of the SAM method [12] to all
genes inside a pathway and the significance level of a
pathway is determined using permutation tests. Then a
core subset is extracted from each significant pathway
identified by the first step on the basis on the magnitudes of individual genes’ SAM statistics. Based on the
simulation results by us [13], SAMGSR may increase the
likelihood of those genes involved in many pathways
being selected. But SAMGSR only considers a gene’s
pathway membership and ignores pathway topology
information, it may miss those ‘driving’ genes with subtle
changes because the inclusion of a gene in the reduced
core subsets hinges on its expression difference between
two phenotypes.
The third category is to create a pathway knowledgebased weight for each gene. For instance, the reweighted
recursive feature elimination (RRFE) algorithm proposed
by Johannes et al. [14] uses GeneRank [15] to calculate a
rank for each gene and then weighs the coefficients in a
support vector machine (SVM) model by this rank. It
had been demonstrated that the resulting gene signatures have better stability and more meaningful biological interpretation [14]. Compared to the other two

RRFE [Johannes
et al. 2010] DRW
[Liu et al. 2013]

categories, while the weighting category is simpler, it has
been underutilized. Its underutilization might be due to
the estimated weights being subject to errors and biases
where the impact on the resulting significant may be
substantial.
In this study, we propose a hybrid method that combines SAMGSR with a pathway topology-based weight
to carry out feature selection. As a combination of the
weighting method and stepwise forward method, the
objective is to address some disadvantages associated
with SAMGSR and the weighting method while utilizing
their strengths. The proposed method is referred to as
weighted-SAMGSR herein. Applying it to both the simulated data and real-world application, we evaluate if
weights reflecting gene connectivity information are
valuable for feature selection.

Methods
Experimental data

We considered two sets of microarray data and one
RNA-Seq dataset in this study. One set of microarray
data is for a multiple sclerosis (MS) application; the
other set and the RNA-Seq data are for a non-small cell
lung cancer (NSCLC) application.
MS data

The MS application consisted of two microarray experiments. The first one included chips from the experiment
E-MTAB-69 stored in the ArrayExpress [16] repository
(http://www.ebi.ac.uk/arrayexpress). All chips were hybridized on Affymetrix HGU133 Plus 2.0 chips. In this study,
there were 26 patients with relapsing-remitting multiple
sclerosis (RRMS) and 18 controls with neurological disorders of a non-inflammatory nature. The second dataset was
provided by the sbv IMPROVER challenge in the year of
2012 [17], which is accessible to the participants on the
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project website (http://www.sbvimprover.com). It was
hybridized on Affymetrix HGU133 Plus 2.0 platform,
and there were 28 patients with RRMS and 32 normal
controls.
NSCLC data

In the non-small cell lung cancer (NSCLC) application,
we considered two cases: the two-class case and the
multiple-class case. For the two-class case, the RNA-Seq
data for those patients at early histology stages (stages I
and II) were downloaded from The Cancer Genome
Atlas (https://tcga-data.nci.nih.gov/tcga/) and served as
the training set. One microarray NSCLC data in the
Gene Expression Omnibus (GEO) repository (accession
No. GSE43580) was used to validate the results.
For the multiple-class case, several microarray data were
used as the training set. They included the data deposited
under accession numbers of GSE10245, GSE18842, and
GSE2109 in the GEO repository. All these 3 experiments
were hybridized on the Affymetrix HGU133Plus 2.0 chips.
Then GSE43580 was used again to evaluate the performance of both SAMGSR algorithms.
Gene sets

Gene sets were downloaded from the Molecular Signatures Database (MSigDB) [18]. In this study, we only
considered the c5 category. This category includes gene
sets annotated by Gene Ontology (GO) terms. The
current version (version 4.0) of MSigDB c5 category
included 1454 gene sets.
Pre-processing procedures

Raw data of E-MTAB-69 were downloaded from the
ArrayExpress repository, and expression values were obtained using the fRMA algorithm [19] and normalization
across samples was carried out using quantile
normalization. The resulting expression values were on
the log2 scale. When there were multiple probe sets
representing the same gene, the one with the largest fold
change was chosen. Raw data of the second set were
downloaded from the sbv challenge website, and were
separately pre-processed in the same way.
For the NSCLC RNA-seq data, Counts-per-million
(CPM) values were calculated and log2 transformed by
Voom function [20] in the R limma package [21]. Raw
data (CEL files) of all NSCLC microarray data sets were
downloaded from the GEO repository, and expression
values were obtained using the fRMA algorithm [19].
Since the training set included data from different microarray experiments, the COMBAT algorithm (http://
www.bu.edu/jlab/wp-assets/ComBat/Abstract.html) was
used to eliminate batch effects. In both two-class and
multiple-class cases, the training sets and the test sets
were pre-processed separately.
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Statistical methods
SAMGSR

SAMGSR extends a pathway analysis method called significance analysis of microarray-gene set (SAMGS) [22]
to identify the ‘core’ subset for each significant gene set.
In SAMGS, the following functional score is defined,
SAMGS j ¼

jjj
X

d 2i ; d i ¼ ðxd ðiÞ−xc ðiÞÞ=ðsðiÞ þ s0 Þ

i¼1

where di is the SAM statistic [12] and calculated for each
gene involving in gene set j, x d ðiÞ and x c ðiÞ are the
sample averages of gene i for the diseased and control
group, respectively. Parameter s(i) is a pooled standard
deviation that is estimated by pooling all samples
together, while s0 is a small positive constant used to
offset the small variability in microarray expression
measurements, and |j| represents the number of genes
within gene set j. A gene set’s significance is estimated
using a permutation test by perturbing phenotype-labels.
For each significant gene set identified by SAMGS, the
genes inside the set are ordered decreasingly based on
the magnitude of di. The additional reduction step of
SAMGSR gradually partitions the entire set into two
subsets: the reduced subset Rk including the first k genes
and the residual one R k including the remaining genes
for k = 1,…, |j|. At each partition, the significance level
of R k was evaluated using the SAM-GS p-value of R k .
The iteration stops when this p-value is larger than a
pre-determined threshold ck for the first time. Figure 1
provides a graphical illustration of the SAMGSR
algorithm.
Weighted-SAMGSR

SAMGSR only assumes the genes within a specific
pathway would function together to impact a biological
process. In SAMGSR, the larger number of gene sets in
which a specific gene is, the larger this gene’s probability
to be selected may be. From the scatterplot (Fig. 2), we
found a moderate positive correlation (Spearman’s
correlation coefficient = 0.191) between the number of
gene sets a gene is involved in and its connectivity level
with other genes, indicating the interactions among
genes provide additional information rather than that
provided by the number of gene sets being contained.
To tackle the ignorance of SAMGSR on gene connectivity information, we propose to combine a weight
constructed on the basis of connectivity information
with the SAMGS statistic. Specifically for G genes under
consideration, a G × G adjacency matrix is defined. Its ij
component aij equals to 1 if genes i and j are connected,
0 otherwise. Because here we only consider an undirected pathway connectivity diagram, this adjacency
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Fig. 1 Diagrams to elucidate both SAMGSR and weighted-SAMGSR algorithms

matrix is symmetric. Then the connectivity weight for
gene i is defined as,
wi ¼

X

aij ; aii ¼ 1

j¼1;…;G

by setting αii = 1, a gene is set to be self-connected and
avoids zero weights for those isolated genes.
In our proposed procedure, we include each gene’s
weight in its SAM statistic to obtain so-called weighted
SAM and weighted SAMGS statistics and then replace
SAM/SAMGS with their weighted counterparts to execute
pathway selection followed by individual gene selection.
The proposed method is referred to as weighted-SAMGSR
herein. In Fig. 1, the definition of weighted SAMGS statistics and where they replace SAMGS statistics are presented.
Within each specific pathway, SAMGSR ranks genes based
on their SAM statistics. In contrast, the weighted-SAMGSR
algorithm assigns genes with high connectivity more
weights. This is motivated to better detect the ‘driving’

genes that are highly connected to other genes but have
subtle expression differences.
In both SAMGSR and weighted-SAMGSR, the cutoff value for ck is regarded as a tuning parameter that
determines the sparseness of the final models. Its
optimal values are determined via k-fold crossvalidations (CVs) by randomly dividing the whole
training dataset into k roughly equal-sized folds. We
apply either SAMGSR or weighted-SAMGSR to k-1 of
these folds and verify their performance on the heldout fold. This step is repeated for each of the k folds
as the held-out fold, and then the error rate is calculated. We then take the optimal cut-off value and
apply SAMGSR or weighted-SAMGSR to the whole
training dataset to select genes in the final models,
whose performances are evaluated using independent
test sets. Of note, since for the SAMGSR methods
the classifiers are not automatically produced along
with the process of feature selection, we fit support
vector machine (SVM) models to estimate the corresponding coefficients of the selected genes.
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Fig. 2 Scatterplot to show the correlation between the number of gene sets one gene is involved and its connectivity. ρ is the estimated
Spearman correlation coefficient between the number of gene sets involved and (1 + the number of connected genes)

The connectivity information was retrieved from
two databases: 1) the Human Protein Reference
Database (HPRD) where the protein-to-protein interaction (PPI) information was downloaded from the
HPRD webpage (www.hprd.org), and then the adjacency matrix among genes was calculated using the
R software; and 2) the STRING software (www.stringdb.org), using both the connectivity among genes and
the scores representing the confidence level on those
connections.

otherwise) is an indicator function for subject i (i =
1,…,n) in class k (k = 1,…,K), and pik denotes the predicted probability for subject i in class k.
BCM and AUPR are two metrics used in the sbv
Improver challenge. Using BCM and AUPR may represent a fair comparison between the weighted-SAMGSR
algorithm and the top-performed teams in this challenge. BCM is defined as,
BCM ¼ 1−

Statistical metrics

As in previous study [23], we use four metrics - Belief
Confusion Metric (BCM), Area Under the PrecisionRecall Curve (AUPR), Generalized Brier Score (GBS),
and misclassified error rate to evaluate the performance
of a resulting gene signature. Specifically, the misclassified
error rate is simply calculated as (false positives + false
negatives/total samples. The cut-off for the confidence
values is set at 0.5, i.e., when a confidence value >0.5 for a
given class then this sample is classified into that class.
For GBS, we used the equation given by Yeung et al [24],
and then further scaled it to the interval of 0 to 1 by
dividing the sample size n,
GBS ¼

1 Xn X K
ðY −pik Þ2
i¼1
k¼1 ik
2n

where Yik (1 if subject i belongs to class k, and 0

1
K


1−

v1
N1





vk
þ ⋅⋅⋅ þ 1−
Nk

which captures the average confidence that a sample
belongs to class k when it indeed belongs to class k.
Then AUPR computed as the average over all classes
k of the AUPRk for each class. The precision is
defined as true positives/(true positives + false positives) while the recall as true positives/(true positives + false negatives). The AUPRk was computed by
sorting the list of subjects in class k according to
their confidences/probabilities. AUPR captures the
ability of correctly ranking the samples known to belong in a given class.
Besides these predictive performance statistics, we
additionally include the Rand index to evaluate the
stability or robustness of the resulting signatures. With k
runs of an algorithm, Rand index is defined as
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k−1
k
∩ jgsi j; gsj 
2 X X
 

k ðk−1Þ i¼1 j¼iþ1 ∪ jgsi j; gsj 

where ∩ represents the size of intersection between two
gene lists and ∪ represents the size of union between
two gene lists gsi and gsj obtained from the ith and jth
runs. Rand index can also be defined at the level of pathways by replacing the gene lists with the pathway lists.
Statistical language and packages

All statistical analysis was carried out in the R language
version 3.1 (www.r-project.org).

Results
Simulated data

Two simulations were used to characterize the
weighted-SAMGSR algorithm and to make comparisons
with the SAMGSR algorithm. Here, we randomly chose
5 gene sets in the MSigDB c5 category. There are approximately 1000 genes inside these 5 gene sets. In the
first simulation, we simulated the gene expression profile
as independent random variables with a standard normal
distribution and the sample size was 60. Then we simulated another set of normally distributed random variables and used it as the test set. In the second simulation,
the observed expression values of the integrated NSCLC
microarray data were used to train the final model. The
expression values were further normalized to have means
of zeros and standard deviations of ones. The standardized
expression values of GSE43580 were used to test the final
model and evaluate its performance.
We chose two genes—HDAC1 and GNAS as the relevant genes and simulated the case and control groups
using the following logit function,
logit 2vs1 ¼ 0:37X HDAC1 −0:86X GNAS
because HDAC1 has the higher connectivity, its coefficient was set as being smaller than that of GNAS. The
simulation results are presented in Table 2.

Overall, the weighted-SAMGSR algorithm outperforms
the SAMGSR algorithm. Specifically, the weightedSAMGSR algorithm has a substantially higher probability
to identify HDAC1 whose signal is about 1.5 times weaker
than GNAS and has better performance statistics in these
two scenarios. Therefore, constructing the weights based
on genes’ topology information and combining those
weights with the SAMGS statistics improve upon the
performance of SAMGSR in terms of correctly selecting
true relevant genes and predictive ability.
Real world data

In this study, we use three applications to evaluate if
weighted-SAMGSR is superior to SAMGSR by accounting
for the additional connectivity information among genes.
Both the MS and NSCLC multi-class applications are
two sub-tasks of the sbv Improver challenge, 2012 [17].
Considered there are 54 teams participated in the
challenge and participants used various feature selection
and classification methods, the best performing teams in
this challenge may indicate the upper limit of a gene
signature/classifier for those data/applications, and the
methods those top-ranked teams used may be
considered as the most suitable ones for those data/applications. A comparison of the weighted-SAMGSR algorithm with those best performing teams is very
meaningful. Therefore, we listed the predictive statistics
of those top-ranked teams and made a comparison
between them and the weighted-SAMGSR algorithm.
Furthermore, two pathway-based feature selection algorithms — RRFE [14] and generalized elastic net (gelnet)
[25] plus two widely-used gene-based methods —
LASSO [26] and penalized support vector machine
(SVM) [27] were considered, and then compared with
both SAMGSR methods.
Two-class cases
MS data

MS is the most prevalent demyelinating disease and the
leading cause of neurological disability in young adults

Table 2 Simulation results
Training set
Method (Sizea)

HDAC1 (%)

Test set
GNAS (%)

Error (%)

GBS

BMC

AUPR

A. Simulated from 60 independent normal-distributed random variables
SAMGSR (3.8)

19

100

16.5

0.118

0.733

0.921

W-SAMGSR (6.23)

65

100

13.2

0.101

0.755

0.948

B. Simulated based on the NSCLC microarray data
SAMGSR (3.94)

0

100

44.5

0.256

0.517

0.550

W-SAMGSR (6.28)

77

100

40.5

0.241

0.534

0.621

Note: W-SAMGSR stands for weighted-SAMGSR
a
stands for average the number of genes selected by either SAMGSR or W-SAMGSR over 100 replicates
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[28]. Here, we analyzed a set of MS real-world data to
explore the discriminative capacity of expression profiles
to separate MS patients from controls, and to
characterize the proposed weighted-SAMGSR method.
Here, the connectivity information was retrieved from
the HPRD database.
The results are presented in Tables 3 and 4. In Table 3,
we observe the selected pathways by SAMGSR and
weighted-SAMGSR with high frequencies differ considerably. On the level of individual genes, there are 6 overlapped
genes. According to the genecards (www.genecards.org)
database, two genes – POLD1 and MRE11A among these 6
genes are directly related with MS. In terms of stability, the
weighted-SAMGSR algorithm shows a slight increment over
the SAMGSR algorithm, i.e., 14.03 % versus 12.83 % at the
gene level and 15.76 % versus 14.04 % at the gene set level.
As shown in Table 4, the performance of SAMGSR is
substantially inferior to that of the top 3 teams in the
sbv challenge. After taking the extra information of gene
connectivity into consideration, the performance of the
weighted-SAMGSR algorithm becomes comparable to
the third team in this sub-challenge. In summary,
weighted-SAMGSR outperforms SAMGSR in terms of
predictive performance and stability.
NSCLC data

NSCLC accounts for approximately 85 % of the lung cancer cases [29]. Lung cancer is a multistage progression
process resulted from genetic sequences mutations, and
thus it is postulated that genes associated with NSCLC patients at histology stage I and with those at stage II might
differ potentially. In this application, we explored the discriminative capacity of expression profiles to separate
NSCLC stage I patients from stage II patients by training
both SAMGSR algorithms on a NSCLC RNA-Seq data set.
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From Table 5, we found there is no overlap between the
selected pathways by SAMGSR and weighted-SAMGSR at
high frequencies. On the level of individual genes, only
CFTR and TGFB2 are identified by both algorithms, indicating these 2 genes not only have large expression differences between stage I and II but also high connectivity with
other genes. According to the genecards database, only
CFTR is directly related to NSCLC. Compared to the
SAMGSR algorithm, the stability of the weighted-SAMGSR
algorithm improves substantially: the Rand index over 10
CV runs increases from 18.28 to 42.15 % on the gene set
level, and increases from 24.48 to 32.38 % on the gene level.
Consistent with the results from the sbv Lung cancer
(LC) challenge [30], two NSCLC early stages cannot be
separated distinctly from each other. Nevertheless,
weighted-SAMGSR outperforms SAMGSR with respect
to all four predictive statistics, as shown in Table 6.
Multiple-class case

Both the SAMGSR algorithm and the weighted-SAMGSR
algorithm can be adopted directly to deal with the multiple classes (>2 groups). Here, we used a set of NSCLC
microarray data to showcase this. In this application, the
patients were categorized into four classes according to
their respective histology subtypes and clinical stages, i.e.,
adenocarcinoma at stage I (AC-I), adenocarcinoma at
stage II (AC-II), squamous cell carcinoma at stage I (SCCI), and squamous cell carcinoma at stage II (SCC-II). To
classify on these four groups, we applied both SAMGSR
algorithms twice — one for the subtype segmentation
and the other for the stage segmentation. Then the final
posterior probabilities are P(AC-I) = P(AC) × P(stage I),
P(AC-II) = P(AC) × P(stage II), P(SCC-I) = P(SCC) ×
P(stage I), and P(SCC-II) = P(SCC) × P(stage II), respectively. The results are given in Table 7.

Table 3 Selected pathways and genes on MS data
SAMGSR

WeightedSAMGSR

Pathways with high frequency (frequency %)

Genes (frequency %)

DNA Directed DNA Polymease Activity (100 %)

POLD4 (100 %)

POLD1 (80 %)

DNA Polymease Activity (90 %)

PHB (80 %)

GPAA1 (70 %)

COVALENT_CHROMATIN_MODIFICATION (70 %)

PIGT (70 %)

DPM3 (70 %)
PI4KB (60 %)

HISTONE_MODIFICATION (70 %)

MRE11A (60 %)

Stability = 14.04 %

Stability = 12.83 %

DNA_RECOMBINATION (70 %) LIPOPROTEIN_BIOSYNTHETIC_PROCESS (70 %)

MRE11A (90 %)

PTPRC (80 %)

NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS (70 %)

BRCA1 (70 %)

ATM (70 %)

PROTEIN_AMINO_ACID_LIPIDATION (70 %)

CHAF1A (70 %)

PIGT (70 %)

DEPHOSPHORYLATION (60 %) INOSITOL_OR_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY (60 %)

GPAA1 (70 %)

PI4KB (70 %)

PEX16 (60 %)

POLD1 (60 %)

POLD4 (60 %)

PPP1CA (60 %)

LIPOPROTEIN_METABOLIC_PROCESS (60 %) PROTEIN_C_TERMINUS_BINDING (60 %)

Stability = 15.76 %

Stability = 14.03 %

Note: Gene symbols in bold are those overlapped genes by SAMGSR and weighted-SAMGSR; gene symbols underlined are directly related to MS according to the
genecards database
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Table 4 Performance statistics of selected genes on MS data
Training set (10-fold CV results)

Test set

A. Performance comparison
Method (n)

Error (%)

GBS

BCM

AUPR

Error (%)

GBS

BCM

AUPR

SAMGSR (52)

34.09

0.244

0.570

0.645

46.67

0.465

0.501

0.725

W-SAMGSR (25)

31.82

0.191

0.611

0.771

43.33

0.341

0.564

0.860

LASSO (30)

34.09

0.275

0.632

0.672

46.67

0.377

0.499

0.747

Penalized SVM(11)

47.73

0.406

0.534

0.630

45

0.569

0.431

0.555

gelnet (169)

34.09

0.251

0.528

0.589

46.67

0.246

0.547

0.746

RRFE (198)

43.18

0.263

0.547

0.619

46.67

0.300

0.523

0.693

B. Performance of the top 3 teams in sbv MS sub-challenge (among 54 teams)
Study (size)

Training data used/Method used

Error (%)

GBS

BCM

AUPR

Lauria’s (n > 100)

E-MTAB-69/Mann-Whitney test, then use top
α % of the selected genes and Cytoscape to
get the clusters on the test set

–

–

0.884

0.874

Tarca’s (n = 2)

GSE21942 (on Human Gene 1.0 ST)/LDA

–

–

0.629

0.819

Zhao’s (n = 58)

7 other data and E-MTAB-69/Elastic net

30

–

0.576

0.820

Note: W-SAMGSR weighted-SAMGSR, LDA linear discrimination analysis, gelnet generalized elastic net by [25], RRFE reweighted recursive feature elimination by [14]
–: not available. Lauria’s Tarca’s and Zhao’s studies [38, 39, 44] are the 3 best studies in the sbv MS sub-challenge

Consistent with the results from the sbv Lung cancer
(LC) challenge [30], the segmentation between stages is
not achievable whereas the segmentation between
subtypes is good. Nevertheless, both SAMGSR algorithms
identify more than 300 genes for the subtype
segmentation while other studies had obtained similar
performance using just one [31] or several genes [23]. We
attribute this to the facts that: 1) SAMGSR is a filter
method [32] that screens the genes one by one and thus
tends to introduce all highly correlated genes to the true
relevant ones into the final model; and 2) the sample size
of this application is relatively large and the SAM statistic,
and consequently SAMGS statistic, are very sensitive to
the sample size. A statistically insignificant difference between two phenotypes with a small sample size would be
regarded as significance when the sample size is

considerably large. Also, the expression difference between AC and SCC is indeed very distinct, compared to
that between stage I and stage II.
By accounting for the connectivity among genes,
weighted-SAMGSR outperforms SAMGSR in these three
real-world applications, which is consistent with the
results from the simulated data. Nevertheless, it is
observed that such superiority differs in these applications — being substantial in the MS application whereas
marginal in the NSCLC application. This may be attributable to that many cancers are under intensive investigation and may be better curated in the major pathway
databases. Therefore, the genes inside one specific
pathway might be more likely to function together for
the cancer cases, making the underlying assumption of
the SAMGSR algorithm more reasonable.

Table 5 Selected pathways and genes on NSCLC RNA-seq data (stage segmentation)
SAMGSR

Weighted-SAMGSR

Pathways with high frequency (frequency %)

Genes (frequency %)

DNA_FRAGMENTATION_DURING_APOPTOSIS (70 %)
SODIUM_CHANNEL_ACTIVITY (70 %)

TGFB2 (80 %) SHROOM2 (80 %) CECR2 (70 %)
SCN4B (70 %) CFTR (70 %)

Stability = 18.28 %

Stability = 24.48 %

ANION_CHANNEL_ACTIVITY (100 %)
CHLORIDE_CHANNEL_ACTIVITY (100 %)
ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY (90 %)
AXON (90 %) APICAL_PART_OF_CELL (90 %)
NEURON_PROJECTION (90 %) ANION_TRANSPORT (80 %)
REGULATION_OF_MAPKKK_CASCADE (80 %) GROWTH_CONE (80 %)
REGULATION_OF_HEART_CONTRACTION (80 %)
REGULATION_OF_MUSCLE_CONTRACTION (80 %)
SITE_OF_POLARIZED_GROWTH (70 %) PROTEIN_FOLDING (70 %)

CFTR (100 %) TGFB2 (80 %) MAPT (80 %)
MAPK8IP3 (70 %) TPM1 (70 %)

Stability = 42.75 %

Stability = 32.38 %

Note: Gene symbols in bold are those overlapped genes by SAMGSR and weighted-SAMGSR; gene symbols underlined are directly related to NSCLC according to
the genecards database
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Table 6 Performance statistics of selected genes on NSCLC
RNA-seq data (stage segmentation)
Training set
(10-fold CV results)
Method (n)

Error GBS
(%)

SAMGSR (9)

35.2

BCM

Test set
AUPR

Error GBS
(%)

0.242 0.539 0. 575 50

BCM

AUPR

0.279 0.507 0.531

W-SAMGSR (8) 32.8

0.231 0.556 0.584

49.3

0.276 0.513 0.580

LASSO (30)

36

0.219 0.558 0.610

50

0.453 0.500 0.509

Penalized
SVM (34)

36.8

0.255 0.562 0.603

50

0.329 0.501 0.518

gelnet (252)

36.8

0.231 0.517 0.547

50

0.465 0.499 0.475

RRFE (93)

35.2

0.185 0.545 0.578

50

0.471 0.500 0.506

Note: W-SAMGSR weighted-SAMGSR, gelnet generalized elastic net,
RRFE reweighted recursive feature elimination

It is also observed that the weighted SAMGSR
algorithm performs comparable to or better than other
feature selection algorithms under consideration, i.e.,
LASSO, penalized SVM, gelnet, and RRFE with respect
to the predictive ability. Regarding to the stability on the
gene level, the weighted SAMGSR algorithm is ranked
second and only outperformed by gelnet that has a Rand
index of 22.52 and 33.66 % in the MS application and
the NSCLC application, respectively. Since both LASSO
and gelnet implement the estimation process using the
cyclic coordinated descent method [33], they require the
least computing time. Penalized SVM and RRFE are the
most computationally intensive, while both SAMGSR algorithms fall in the middle.
In addition, the PPI information in the STRING database [34] were used to construct the adjacent matrixes
and to illustrate the utility of the weighted-SAMGSR

algorithm, while different databases may contain different gene connectivity information. Table 8 presents the
performance statistics for the weighted-SAMGSR algorithm using both the connectivity information and the
confidence values for those interactions. The conclusion
that the weighted-SAMGSR algorithm is superior to the
SAMGSR algorithm remains persistently true for all three
applications. Moreover, the performance of weightedSAMGSR using the confidence values tends to be better
than that using the dichotomized values. Further investigations should consider the choice of databases to retrieve
the gene connectivity information and which values for
the weights for one specific application.

Conclusions
Although SAMGSR is a pathway-based feature selection
algorithm in nature, it treats all genes inside one pathway
equally and assumes the genes in one specific pathway cofunction together to regulate biological processes. To
tackle its major drawback of discarding the gene topology
knowledge, we propose a weighted extension to SAMGSR
by creating weights based on the connectivity among
genes and combining those weights with the SAMGS
statistics. Using simulations and multiple real-world applications, we demonstrated that this weighted version of
SAMGSR outperforms the original SAMGSR algorithm.
In addition, the weight construction is very straightforward and has added little computational burden to the
algorithm. Therefore, the weighted-SAMGSR algorithm is
preferred over the SAMGSR algorithm.
Currently, pathway-based feature selection algorithms
have become a topic of increasing interest in the field
bioinformatics. Incorporating additional meaningful

Table 7 Performance statistics of selected genes on NSCLC data (multiple-class case)
Training set (5-fold CV results)

Test set

A. Performance comparison
Method (n)

Error (%)

GBS

BCM

AUPR

Error (%)

GBS

BCM

AUPR

SAMGSR (30)

40.7

0.279

0.377

0.462

51.3

0.348

0.407

0.486

W-SAMGSR (27)a

37.2

0.276

0.378

0.453

51.3

0.345

0.405

0.492

LASSO (95)

38.6

0.281

0.458

0.483

52.7

0.395

0.456

0.485

pSVM (>100)

42.8

0.370

0.344

0.428

53.3

0.433

0.385

0.397

gelnet (>400)

36.6

0.284

0.346

0.416

54.7

0.343

0.377

0.489

RRFE (>200)

36.6

0.272

0.395

0.448

54

0.336

0.410

0.468

Error (%)

GBS

BCM

AUPR

a

B. Performance of the top 3 teams in sbv NSCLC sub-challenge (among 54 teams)
Study (size)

Training data used/Method used

Ben-Hamo’s (23)

GSE10245, GSE18842, GSE31799/PAM

49.3

–

0.48

0.46

Tarca’s (25)

GSE10245, GSE18842, GSE2109/moderated t-tests + LDA

–

–

0.459

0.454

Tian’s (66)

GSE10245, GSE18842, GSE2109/TGDR in hierarchical way

53.3

0.374

0.440

0.471

Note: W-SAMGSR weighted-SAMGSR, pSVM penalized support vector machine (SCAD penalty term), gelnet generalized elastic net, RRFE reweighted recursive
feature elimination, LDA linear discriminant analysis, PAM partitioning around medoid, TGDR threshold gradient descent regularization
a
The sizes of final model for the stage segmentation because the results for the subtype segmentation for both algorithms are identical (but the final size > 300).
Ben-Hamo’s study [31], Tarca’s study [44] and Tian’s study [45] are the 3 best studies in the sbv LC sub-challenge
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Table 8 Performance statistics on the test set for the weightedSAMGSR algorithm (PPI information retrieved from the STRING
database)
No.

Error
(%)

GBS

BMC

AUPR

Rand
(gene)

Rand
(GS)

MS (b)

22

43.3

0.279

0.581

0.847

15.3 %

27.1 %

MS (c)

20

28.3

0.179

0.613

0.828

15.5 %

25.4 %

Stage for LC (b)

32

45.3

0.318

0.520

0.552

36.3 %

40.1 %

Stage for LC (c)

26

45.3

0.274

0.525

0.566

35.8 %

40.4 %

MC for LC (b)

a

22

47.3

0.337

0.411

0.510

–

–

MC for LC (c)

31a

51.3

0.334

0.410

0.512

–

–

Note: (b): using the binary values indicating if two genes are connected or not;
(c): using the confidence scores for the gene connectivity. MS: the multiple
sclerosis application; Stage for LC: the NSCLC stage application trained on the
RNA-Seq data; MC for LC: the NSCLC multiple-class application. Rand (gene):
the rand index at the gene level, across the gene lists obtained from 10-fold
cross-validation data; Rand (GS): the rand index at the gene set level
a
is the number of selected genes for the stage segmentation, the number of
selected genes for the subtype segmentation > 300

information does facilitate feature selection [25]. However,
the pathway knowledge is far from completeness and thus
is subject to changes and errors, which limits the use of
those pathway-based methods in practice. To address this,
we recommend analyzing the real-world data with both
gene-based methods and pathway-based methods such as
the weighted-SAMGSR algorithm and to explore if the
pathway knowledge is informative for the specific data.

Reviewers’ reports
Round 1
Reviewer’s report 1: Dr. Limsoon Wong, National
University of Singapore, Singapore
Reviewer summary

1/This paper is badly organized and badly written, and
the abstract is written in a way that lacks appeal. This
makes the paper unattractive to readers. 2/The performance evaluation is limited and unconvincing. In particular,
the cross-dataset error rate was ~40 %, which is unusable;
and the stability of feature selection was ~14 %, which is
essentially no stability. Furthermore, it was not compared
to convincing competing methods. This makes the
method unattractive for practical use. 3/There is not
much discussion and analysis of results. This makes it
difficult for readers to gain much useful insights. 4/The
review of existing methods seems to have omitted a
major category (which includes famous geneset-based
methods like GSEA), and there is little effort to articulate the novelty of the proposed method against the
very extensive collection of past works.
Reviewer recommendations to authors

1/This paper is badly organized and written. The followings are some major presentation issues (and there are
many other presentation issues).

- The proposed weighted-SAMGSR method is not
described clearly and is not described under the method
section. Its description got mixed up in the results
section. Its novelty is not articulated and, whatever the
novelty is, its contribution to improving performance is
not very well explained and evaluated in depth.
Author’s response: We have moved the description on
the weighted-SAMGSR method to the Methods section,
and added additional analyses to explore the proposed
method more comprehensively.
- The existing method SAMGSR that it claims to
improved on, as described in the method section, is
different from that described in the intro and results
section. In particular, the one in the methods section
says nothing about “SAMGSR assumes that the number
of gene sets within which a specific gene is contained is
highly correlated with the pathway connectivity” and
does not say how it ranks genes across significant gene
sets (it just ranks gene sets).
Author’s response: Based on our experience of using
SAMGSR, the probability to be selected is positively
correlated to the number of gene sets this particular gene
is involved. To clarify this, we have rephrased the
corresponding sentences.
In the reduction step of SAMGSR, the genes within a
specific selected gene set were ordered according to its
SAM statistic (or more precisely, the p-value of its SAM
statistic). Starting from the gene with the most significant p-value, the whole gene set was divided into two
subset: the reduced subset and its complement, then the
p-value of SAMGS statistic for the complement set is
compared with a cutoff value ck. If this p-value is less
than ck , the next gene is added to the reduced subset
and deleted from the complement set. This step iterates
until this p-value is larger than ck for the first time. The
selected genes by SAMGSR are the union of genes inside
those reduced sets.
- The stability is evaluated by Rand index for k runs. It
is not clear what k runs is. For each disease you have a
pair of datasets. I suppose k = 2? Also, other evaluation
metrics are named but not defined in the manuscript;
not self contained.
Author’s response: Sorry for not stating this explicitly in
the manuscript. k refers to the number of folds in the crossvalidation. For the MS and NSCLC two-case applications,
we conducted a 10-fold cross-validation and thus k = 10.
Regarding other metrics used, we have added their
definitions in the Methods section.
2/The performance evaluation is limited and unconvincing.
- More datasets should be tried.
Author’s response: We have applied the weightedSAMGSR algorithm to more datasets. Specifically, a non
small-cell lung cancer (NSCLC) RNA-Seq data set was
tried, as suggested by Reviewer 3.
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- The error rate and stability reported are unimpressive.
Cross-dataset error rate was ~40 %, not much better than
random and hence unusable. Stability was ~14 %, also not
much better than random, and would be far below those
of e.g. PFSNet [35], ESSNET [36], or GAT [37].
Author’s response: Ideally, a Rand Index, a BCM, and
an AUPR being closer to 1’s while a GBS and an error
rate being closer to 0 represent a better segmentation between classes. In practice, however, the best scores on
these metrics depend on the applications. Thus we
believe that the relative values of those metrics play a
more important role when comparing across methods. In
terms of those performance metrics, the weightedSAMGSR algorithm has been demonstrated to outperform the SAMGSR algorithm. (Of note, the error rate is a
threshold-dependent metric. Here, we used 0.5 as the
cutoff, which might not be the optimal one.)
Specifically, for the stability (i.e., the Rand index),
we took the average over 45 pairs (for the 10 gene
lists obtained from 10-fold CVs). Considered the sample
size of the training set is just moderate, it is nonsurprising that the values of Rand index are small. Rand
index depends on applications, too. For example, the
pathway-level agreement of PFSNet is 100 % for the
leukemia application but is 56 % for the ALL application
(as shown in ref. [35]). The weighted-SAMGSR algorithm
is superior to the SAMGSR algorithm in terms of stability.
- The performance is compared against a few past
methods. But it is not clear that these methods are the
best or more well known ones that use gene set or
pathway information.
Author’s response: The reason we chose the MS and
NSCLC multi-class applications to illustrate the proposed
method is because they are two sub-tasks of the sbv
Improver challenge, 2012. Considered there are 54 teams
participated in the sbv challenge and participants used
various feature selection and classification methods, we
think the best performing teams in this challenge may
indicate the upper limit (the best performance) of a gene
signature/classifier for those data/applications, and the
methods those top-ranked teams used may be considered
as the most suitable ones for those data/applications.
Therefore, a comparison of the weighted-SAMGSR with
those best performing teams may be more valuable. Notably, among the best performing teams, several of them account for the pathway information, e.g., [38] and [39].
3/Past works cited on gene set-based methods strangely
omits famous ones like GSEA, Irizarry et al., etc. In fact,
the 3 categories into which the authors put past gene setbased methods into don’t fit these famous methods.
Author’s response: We defined a pathway-based feature
selection method differently from a gene set analysis
method, which explores the association between a whole
pathway and the phenotype of interest. In contrast, a
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pathway-based feature selection algorithm incorporates
pathway knowledge to guide the selection of individual
genes that are associated with the phenotype. Based on
these definitions, GSEA and other well-known methods like
Pathifier [40] and SAMGS [22] are classified as a gene set
analysis method, which concerns about the identification
of relevant pathways. Therefore, they were not included in
the Background section.
We are sorry for not emphasizing this essential
difference between a gene set analysis method and a
pathway-based feature selection method. To address
this, we have clarified on this specifically and explicitly
in the Background section.
4/The background emphasizes stability of feature
selection. However, the evaluation of stability is quite
limited and not emphasized/presented very well.
Author’s response: Sorry for this inconsistency. We
have added more evaluation on the stability using the
NSCLC application (stage I versus II segmentation using
RNA-seq data) and discussed more about the corresponding results.
5/There is not much discussion and analysis of results.
Without an in-depth serious discussion and analysis of
results, it is difficult for the reader to gain much insight.
Author’s response: We have added more discussion on
the results.
Minor issues

The English is very poor. Too many mistakes to list here.
Author’s response: We have edited the English exclusively.
Reviewer’s report 2: Dr. Lev Klebanov, Charles University,
Czech Republic
Reviewer summary

Authors did not mentioned some problems connected
to normalization procedure and to multidimensional
character of pathways. They have to add corresponding
information into the paper.
Reviewer recommendations to authors

The authors describe their aims as follows: “In this study,
we propose a hybrid method that combines SAMGSR
with a pathway topology-based weight to carry out feature
selection”.
The idea of taking into account the topology structure
of pathways seems to be very interesting and promising.
However, I have doubts about the correctness of considerations given in the manuscript. Two arguments for
such doubts are given below.
1. Pathway is a multidimensional structure. Dependences
between genes in pathway are very essential. However, the
authors use quantile normalization as a pre-processing
procedure. It is known [41, 42] that quantile normalization
destroys correlation structure between genes. Therefore, its

Tian et al. Biology Direct (2016) 11:50

application looks to be strange, and, at least, needs to be
explained in more details.
Author’s response: Thank you for this insightful comment. As demonstrated in [41], quantile normalization
may destroy both the spurious correlation structure and
the true correlation structure between genes. This should
have small impact on the weighted-SAMGSR algorithm
given the weights in the weighted-SAMGSR algorithm
were constructed on the basis of the PPI information,
which was retrieved from major canonical databases,
instead of the de novo networks constructed using the
expression values.
Furthermore, we have analyzed a non-small cell lung cancer RNA-Seq dataset using the expression profiles obtained
by the Voom function (without quantile normalization).
The conclusion that the weighted-SAMGSR algorithm
is superior to the SAMGSR algorithm holds true in this
application.
2. I do not see how pathway multidimensionality is
used in the manuscript. The attempts to use it were
proposed in [43]. I thing, the distance between pathways
and genes in pathway is neither “statistical metric” nor
Euclidean distance. Unfortunately, the choice of distance
is not explained in the manuscript. Author just mentioned statistical metric without explanation of its
suitability.
Basing on these arguments, I propose to the authors
to add detailed explanations of the points mentioned
above.
Author’s response: The metrics in [43] are good statistics to evaluate the performance of a gene set analysis
method. Nevertheless, this study focuses on the pathwaybased feature/gene selection algorithms, which has essentially a different definition. While a gene set analysis
method selects relevant pathways, a pathway-based
feature selection algorithm identifies relevant genes but
using pathway knowledge as a priori to guide the selection process.
The statistical metrics we used in this study are
suitable for evaluating the performance of a feature/
gene selection algorithm. To clarify this, we have added
their definitions in the Methods section and emphasized on their suitability to evaluate and compare the
predictive performance of different feature/gene selection methods.
Reviewer’s report 3: Dr. I. King Jordan, Georgia Institute
of Technology, USA
Review summary

This manuscript reports a pathway-based feature selection method that incorporates prior biological information into the selection of a set of genes of interest based
on the results of large-scale differential expression
analysis between phenotypic conditions using microarrays.
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The method reported here is an extension of the previously developed significance analysis of microarray-gene
set reduction algorithm (SAMGSR) from a different research group. The authors’ extended method entails a
weighting step that takes pathway network topology into
consideration and results in a reduction of the pathways
selected for further analysis to their core constitutive
genes, thereby yielding a more focused, and presumably
more biologically relevant, subset of genes for subsequent
analyses. It does this by incorporating a weight feature
that is based on network connectivity (from proteinprotein interactions in this case); genes with high connectivity are weighted more heavily in an effort to detect driver
genes that may have more systemic influences on gene
expression. This extension, while somewhat trivial, does
seem to make intuitive sense, and the authors’ benchmarking analyses support its use.
Reviewer recommendations to authors

Methods of this kind are certainly of interest, in
principle, to the biological research community and have
the potential to better direct follow on experiments and
eliminate wasted effort. My main concern is that given
the fact that the manuscript is reporting an extension of
an existing method, the bar is high with respect to both
providing for and demonstrating the utility of the
extended method. I feel that the authors should do more
to 1) broaden the scope of their method, 2) demonstrate
its utility, and 3) make it available to the research
community.
1. The adjacency matrix used by the method is binary
and allows genes to be connected (1) or not (0). It would
be desirable to allow for edge weights to allow for the incorporation of confidence levels with respect to gene
(protein) interactions.
Author’s response: Thanks for the suggestion. Given the
PPI information we downloaded from HPDB has only
binary values (indicating if gene pairs are connected or
not), we now also consider the STRING database to get
the edge weights with confidence levels and apply the
weighted-SAMGSR algorithm to demonstrate its utility.
Please see Table 8 for the results of these analyses.
2. The network connections used correspond to
protein-protein interactions. However, there are many
different kinds of interactions that contain biologically
relevant information and are widely available. For example, the STRING database has different classes of
protein-protein interactions as well as predicted interactions based on gene neighborhood, protein homology
and text mining. The authors should explore the utility
of different sources of gene (protein) interactions.
Author’s response: We have added the analysis using
the PPI information provided by the STRING database
(using both confidence levels and binary values).
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3. The benchmarking analysis is limited to two
microarray data sets (from the exact same array platform).
RNA-seq is of course widely used for differential expression studies of the kind analyzed here, and the authors
should also test one or two RNA-seq data sets.
Author’s response: We have added more analyses using
an RNA-seq non-small cell lung cancer dataset, downloaded from The Cancer Genome Atlas (TCGA) project.
4. I could not find any indication of whether, or how,
this method has been made available for the research
community. The utility of this method would be greatly
enhanced if the code, along documentation for how to
use it, were released on a software repository such as
GitHub. [Note that this can be done with the appropriate license if the authors are concerned about commercial applications].
Author’s response: We are working on an R Bioconductor package including the weighted-SAMGSR algorithm
(the work proposed in this manuscript) and two extensions to SAMGSR for longitudinal data analysis (the
manuscript had been uploaded in Arxiv). We intend to
present this package in a software paper.
Nevertheless, in order to make the immediate use of
the proposed methods by other researchers possible, we
have added an Additional file 1 that presents the R
program for the weighted-SAMGSR algorithm.

Round 2
Reviewer’s report 1: Dr. Limsoon Wong, National
University of Singapore, Singapore
Reviewer comments to Authors

1/There is some problems in the PDF file. In particular, in
many formula, some symbols are missing (they show up as
empty boxes). As these formula are critical to understanding the proposed method and evaluate its correctness, I
am unable to proceed reviewing the ms very carefully.
Author’s response: Sorry the PDF file displayed these
equations improperly. We had used an older version of
Office on a MacBook, which somehow made the equations out of place. We have reformatted the Word file
and addressed this problem.
Nevertheless, a quick scan of the ms shows that most of
my earlier comments have not been addressed very well.
E.g.: 2/The point of my mentioning existing methods (like
PFSNET, ESSNET, GSEA, Irizarry et al. and so on) is that
the proposed method has not been compared with a convincing set of competing methods. It does not matter what
approach classes these methods belong to, they are methods
for solving the same problem as the proposed method.
Hence to demonstrate how well the proposed method is
doing against current methods, it is important see comparison against a broader range of existing methods.
Author’s response: Besides LASSO and penalized
SVM, we now have analyzed those datasets using two
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additional pathway-based feature selection algorithms —
generalized elastic net (gelnet, a penalty method) [25]
and reweighted recursive feature elimination (RRFE, a
weighting method) [14], and have compared these
methods to the proposed weighted SAMGSR algorithm.
As there are numerous existing feature selection
algorithms, an exhaustive comparison between those
methods and the weighted SAMGSR algorithm is
impractical. We note that the sbv Improver challenge
allowed comparison between some of the bestperformed methods and our proposed method for the
specific application.
3/The point of my mentioning the poor stability and
cross-dataset error rate is that a good method should
choose features that are reproducible and useable in
future data. Otherwise the chosen features cannot be
used in practice and are likely not causal to the phenotypes studied. That is, it is a signal that the results are
not sound. Soundness is a crucial factor for/Biology
Direct/in considering manuscripts. Hence the authors
should properly investigate the poor stability and crossdataset error rate of the proposed method, understand
what causes this, and properly acknowledge and discuss
the issue. The authors should make a further major
revision to address these and other points raised in my
previous review.
Author’s response: First, we agree with the reviewer
that chosen features with poor stability cannot be used in
practice. Consequently, we don’t make any recommendation on the resulting gene or gene set signatures that
should be used in practice. Our primary objective here is
to introduce the weighted SAMGSR algorithm. Using
simulations and multiple real-world applications, we
have demonstrated that weighted SAMGSR is superior to
the original SAMGSR algorithm.
Second, regarding poor stability and predictive errors
(based we note that these metrics are all data/application
dependent. There are various examples to illustrate this.
For example, in one article mentioned by the reviewer
[37], PFSNet has an AUC of 0.556 and a recall of 0.667
on a colorectal cancer data whereas an AUC of 0.666
and a recall of 0.937 on another colorectal cancer data.
Regarding stability, the between-dataset gene-set level
agreement and gene-level agreement for PFSNet on the
colorectal datasets are only 21.59 and 12.41 %, respectively. For different applications, the fact that gene
expression profiles present different amounts of information and noises should be well acknowledged.
Reviewer’s report 2: Dr. Lev Klebanov, Charles University,
Czech Republic
Reviewer comments to authors

I have no additional comments. My previous comments
were taking into account. All questions were answered.
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Reviewer’s report 3: Dr. I. King Jordan, Georgia Institute
of Technology, USA
Reviewer comments to authors

6.

I am satisfied that my original comments have now been
addressed and recommend that the revised article be
accepted for publication.

8.
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Additional file 1: R codes for the weighted-SAMGSR algorithm.
(DOCX 76 kb)
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